<i>In vitro</i> release profile of rhTGF-β<sub>3</sub> from the EMLDS.
Soon Sim Yang
Long Hao Jin
Sang-Hyug Park
Moon Suk Kim
Young Jick Kim
Byung Hyune Choi
Chun Tek Lee
So Ra Park
Byoung-Hyun Min
10.1371/journal.pone.0156292.g003
https://plos.figshare.com/articles/figure/_i_In_vitro_i_release_profile_of_rhTGF-_sub_3_sub_from_the_EMLDS_/3417523
<p>(A) Samples incubated in PBS were collected for 30 days and the amount of released rhTGF-β<sub>3</sub> was examined using ELISA. Approximately 86% of the total rhTGF-β<sub>3</sub> loaded was released from the EMLDS after 28 days. (B) The release rate of rhTGF-β<sub>3</sub> was approximately 8 ng/day for the first five days and approximately 4 ng/day thereafter. The release profiles did not significantly differ when the amount of rhTGF-β<sub>3</sub> loaded was varied from 50 ng to 200 ng.</p>
2016-06-03 11:55:05
rhTGF
Articular Cartilage Repair Recombinant
Successful cartilage repair
novel drug delivery system
vivo models
ECM
Sustained Releasing Growth Factor Delivery System
drug delivery system
MSC
EMLDS